The anemia of ageing is not associated with increased plasma hepcidin levels

Blood Cells, Molecules, and Diseases

Volumn 41, Issue 3, 2008, Pages 252-254

  Lee, Pauline ^a   Gelbart, Terri ^a   Waalen, Jill ^a   Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Ferritin; Hemoglobin; Immunoassay; Inflammation

Indexed keywords

FERRITIN; HEPCIDIN; INTERLEUKIN 6;

ADULT; AGED; AGING; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; LUPUS ERYTHEMATOSUS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS;

AGED; AGED, 80 AND OVER; AGING; ANEMIA; ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; FEMALE; FERRITINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 53149105493     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.06.005     Document Type: Article

References (18)

1. Lipschitz D.A., Mitchell C.O., and Thompson C. The anemia of senescence. Am. J. Hematol. 11 (1981) 47-54
2. Beutler E., and Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?. Blood 107 (2006) 1747-1750
3. Shayne M., and Lichtman M.A. Hematology in older persons. In: Lichtman M.A., Beutler E., Kipps T.J., Seligsohn U., Kaushansky K., and Prchal J. (Eds). Williams Hematology (2006), McGraw-Hill, New York 111-121
4. Eisenstaedt R., Penninx B.W., and Woodman R.C. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 20 (2006) 213-226
5. Felker G.M., Adams K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J. Am. Coll. Cardiol. 44 (2004) 959-966
6. Lee P.C., Kini A.S., Ahsan C., Fisher E., and Sharma S.K. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J. Am. Coll. Cardiol. 44 (2004) 541-546
7. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Cohen D.A., Negoita M., Lansky A.J., and Stone G.W. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention - analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J. Am. Coll. Cardiol. 44 (2004) 547-553
8. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B.J., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
9. Zakai N.A., Katz R., Hirsch C., Shlipak M.G., Chaves P.H., Newman A.B., and Cushman M. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch. Intern. Med. 165 (2005) 2214-2220
10. Kemna E.H., Tjalsma H., Podust V.N., and Swinkels D.W. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin. Chem. 53 (2007) 620-628
11. Murphy A.T., Witcher D.R., Luan P., and Wroblewski V.J. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 110 (2007) 1048-1054
12. Dallalio G., Fleury T., and Means R.T. Serum hepcidin in clinical specimens. Br. J. Haematol. 122 (2003) 996-1000
13. T. Ganz, G. Olbina, D. Girelli, E. Nemeth, M. Westerman, Immunoassay for human serum hepcidin. Submitted for publication.
14. Beutler E., Felitti V.J., Koziol J.A., Ho N.J., and Gelbart T. Penetrance of the 845G->A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359 (2002) 211-218
15. Kearney S.L., Nemeth E., Neufeld E.J., Thapa D., Ganz T., Weinstein D.A., and Cunningham M.J. Urinary hepcidin in congenital chronic anemias. Pediatr. Blood Cancer 48 (2007) 57-63
16. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
17. Nemeth E., Roetto A., Garozzo G., Ganz T., and Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 105 (2005) 1803-1806
18. Tomosugi N., Kawabata H., Wakatabe R., Higuchi M., Yamaya H., Umehara H., and Ishikawa I. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System(R). Blood 108 (2006) 1381-1387